PhytoHealth (TPE:4108) Cyclically Adjusted PB Ratio: (As of Aug. 05, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:4108 PhytoHealth Corp TPE:4108
72 GF Score
Price NT$11.20
GF Value NT$15.94
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is PhytoHealth Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


PhytoHealth  (TPE:4108) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


PhytoHealth Cyclically Adjusted PB Ratio Related Terms


PhytoHealth Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for PhytoHealth's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PhytoHealth Cyclically Adjusted PB Ratio Chart

PhytoHealth Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.81 1.46 1.75 1.42 1.19

PhytoHealth Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.23 1.18 1.30 1.19 0.00

TPE:4108 vs ZTS: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, PhytoHealth's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PhytoHealth Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PhytoHealth's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where PhytoHealth's Cyclically Adjusted PB Ratio falls into.


TPE:4108
72GF Score
PhytoHealth Corp TPE:4108
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PhytoHealth Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

PhytoHealth's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 is calculated as:

For example, PhytoHealth's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book=Book Value per Share/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=9.245/330.2130*330.2130
=9.245

Current CPI (Mar. 2026) = 330.2130.

PhytoHealth Quarterly Data

Book Value per Share CPI Adj_Book
201606 11.617 241.018 15.916
201609 11.426 241.428 15.628
201612 11.149 241.432 15.249
201703 10.941 243.801 14.819
201706 10.741 244.955 14.479
201709 10.463 246.819 13.998
201712 9.959 246.524 13.340
201803 9.843 249.554 13.024
201806 9.546 251.989 12.509
201809 9.322 252.439 12.194
201812 8.661 251.233 11.384
201903 8.569 254.202 11.131
201906 8.389 256.143 10.815
201909 8.161 256.759 10.496
201912 7.723 256.974 9.924
202003 7.269 258.115 9.299
202006 7.652 257.797 9.801
202009 7.637 260.280 9.689
202012 7.609 260.474 9.646
202103 10.040 264.877 12.517
202106 10.096 271.696 12.270
202109 10.088 274.310 12.144
202112 9.972 278.802 11.811
202203 9.880 287.504 11.348
202206 9.564 296.311 10.658
202209 9.659 296.808 10.746
202212 9.606 296.797 10.688
202303 9.600 301.836 10.503
202306 9.834 305.109 10.643
202309 9.672 307.789 10.377
202312 9.703 306.746 10.445
202403 9.962 312.332 10.532
202406 9.818 314.175 10.319
202409 9.715 315.301 10.174
202412 9.573 315.605 10.016
202503 9.472 319.799 9.780
202506 9.292 322.561 9.512
202509 9.297 324.800 9.452
202512 9.429 324.054 9.608
202603 9.245 330.213 9.245

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is PhytoHealth (TPE:4108) Overvalued in 2026?

Based on GuruFocus' analysis, PhytoHealth stock appears to be undervalued. The current stock price of NT$11.20 is trading 29.7% below its estimated GF Value™ of NT$15.94. GuruFocus considers PhytoHealth to be Significantly Undervalued.

Key valuation signals for TPE:4108:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: NT$15.94 vs. price of NT$11.20 (29.7% below fair value)
  • GF Score™: 72/100 with 2 warning signs

No single metric tells the full story. See the TPE:4108 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PhytoHealth Business Description

Address Fuxing North Road, No. 167, 5th Floor - 1, Zhongshan District, Taipei, TWN, 104
PhytoHealth Corp engages in the research and development, production, manufacture, and sale of pharmaceutical drugs, cosmetics, Class B drugs, and dietary supplements. The company's product portfolio comprises White Blood Crystals Injection, White Pain Relief Soft Capsules, WhiteGilead, and White AminoSpeed supplements. Additionally, it is developing PHN031 (White Bone) for the prevention of osteoporosis; PHN033 (White Sugar) for the treatment of diabetic nephropathy; PHN016 for cancer treatment; and PHN017 for the treatment of cytokine storm. The company's reportable operating segments are: Pharmaceutical drugs and dietary supplement, which generate maximum revenue, Medical diagnostic products, and Precision medical equipment. Geographically, it derives maximum revenue from Taiwan.
72GF Score

Get the complete analysis for TPE:4108

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$11.20
Price
NT$15.94
GF Value